Filter By IndustryNone Found
Filter By Tag
Kindred Biosciences, Inc. Press releases1 - 7 of 7 Press Releases
May 03, 2013
Antibody therapy is expected to be a major advance in the treatment of dogs with severe immunologic conditions.
Mar 26, 2013
KIND-005 is expected to be a major new therapy for the treatment of laminitis in...
Feb 01, 2013
KIND-002 is expected to be a major new therapy for severe cutaneous diseases in dogs.
Jan 22, 2013
Highly Regarded Veterinary Marketing Executive to Join Kindred Bio’s Board
Dec 31, 2012
KIND-001, a potent and specific inhibitor of inflammatory cytokines, is expected to be a major new therapy for diseases in dogs.
Nov 05, 2012
Distinguished Pharmaceutical Executive to Join Kindred Bio’s Board
Oct 09, 2012
Breakthrough technology to save lives and alleviate suffering in dogs, cats, and horses
RSS Feed for Kindred Biosciences, Inc. Press Releases